Science Explorer Interactive view Map
Company · London · United Kingdom

EVRAZ (United Kingdom)

In research, EVRAZ (United Kingdom) stands highest in Health Sciences (#17,121 of 20,462 worldwide), over all time.

evraz.com/enROR OpenAlex
World rank, 2022–2025
#19,025
of 28,054 · #32,606 all time
Rank in United Kingdom
#670
of 1,094
Research works
250
▲ 67% vs 2013–17
Citations
1.5k
6.1 per fractional work
Top-10% rate
12.0%
record average 16.5%
Open access
49%
world 28%

What is EVRAZ (United Kingdom) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #17,121 of 20,462 11.1%131

Each strip is that field’s whole ranked pool, with the notch where EVRAZ (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.87× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 4.22× its world share, 4 worksImmunology and Micro…Neuroscience: 0.82× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.92× its world share, 1 worksPharmacology, Toxico…Computer Science: 0.19× its world share, 1 worksComputer ScienceEngineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 0.18× its world share, 1 worksEnvironmental ScienceMathematics: 3.34× its world share, 3 worksMathematicsHealth Professions: 2.01× its world share, 4 worksHealth ProfessionsMedicine: 2.45× its world share, 40 worksMedicineBusiness, Management and Accounting: 0.19× its world share, 0 worksBusiness, Management…Decision Sciences: 1.44× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 8.34× its world share, 15 worksEconomics, Econometr…Psychology: 2.13× its world share, 6 worksPsychologySocial Sciences: 0.26× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 8.3×. Every wedge is a field page.

Who are the top researchers at EVRAZ (United Kingdom)?

Ranked on the composite score, Ike Iheanacho, Kevin Marsh and Dimitra Lambrelli lead among researchers whose main affiliation is EVRAZ (United Kingdom).

  1. 1 Ike Iheanacho United Kingdom · #644,110 worldwide 34 citations · 18 works
  2. 2 Kevin Marsh United Kingdom · #1,175,876 worldwide 21 citations · 28 works
  3. 3 Dimitra Lambrelli United Kingdom · #1,379,638 worldwide 4 citations · 15 works
All ranked researchers at EVRAZ (United Kingdom)

Which keywords describe research at EVRAZ (United Kingdom)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Epidemiology, Clinical Trials, Pathogenesis, Immunotherapy and Prognostic Factors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology11▲ 3.2×45 topics
  2. Quality of Life10▲ 8.1×13 topics
  3. Cost-effectiveness Analysis8▲ 117×1 topic
  4. Health Utility Measures8▲ 117×1 topic
  5. Clinical Trials4▲ 6.5×8 topics
  6. Immunotherapy3▲ 5.4×8 topics
  7. Pathogenesis3▲ 7.4×8 topics
  8. Biomarkers3▲ 5.1×5 topics
  9. Prognostic Factors3▲ 7.5×6 topics
  10. Vaccine3▲ 7.8×4 topics
  11. Pharmaceutical Industry3▲ 82×2 topics
  12. Guidelines2▲ 6.4×5 topics
  13. Lymphoma2▲ 18×2 topics
  14. Bayesian Methods2▲ 55×2 topics
  15. Immunity2▲ 6.5×3 topics
  16. Chronic Disease Management2▲ 13×4 topics
  17. Drug Development Costs2▲ 94×1 topic
  18. Generic Drugs2▲ 94×1 topic
  19. Meta-Analysis2▲ 4.2×8 topics
  20. Leadership2▲ 5.0×6 topics
  21. Medication Adherence2▲ 43×2 topics
  22. Professional Development2▲ 12×4 topics
  23. Clinical Management2▲ 13×4 topics
  24. Genetic Variants2▲ 13×3 topics
  25. Rituximab2▲ 15×3 topics
  26. Drug Development2▲ 24×2 topics
  27. Experimental Design2▲ 58×2 topics
  28. Health Outcomes2▲ 7.7×3 topics
  29. Adverse Drug Reactions2▲ 38×2 topics
  30. COVID-19 Vaccine2▲ 28×1 topic
  31. Conjoint Analysis2▲ 50×1 topic
  32. Discrete Choice Models2▲ 68×1 topic
  33. Off-Label Drug Use2▲ 73×1 topic
  34. Pediatric Pharmacokinetics2▲ 73×1 topic
  35. Targeted Therapy2▲ 9.0×3 topics
  36. Vaccine Hesitancy2▲ 30×1 topic
  37. Bacterial Meningitis2▲ 96×1 topic
  38. Evidence-Based Practice2▲ 15×3 topics
  39. Neisseria meningitidis2▲ 96×1 topic
  40. Chronic Disease2▲ 10×2 topics

Which research topics does EVRAZ (United Kingdom) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Vaccine Coverage and Hesitancy and Pharmaceutical studies and practices.

Health Systems, Economic…8Health Systems, Economic Evaluations, Quality of Life: 8 fractional worksPharmaceutical Economics and Policy: 2 fractional worksVaccine Coverage and Hesitancy: 2 fractional worksPharmaceutical studies and practices: 2 fractional worksEconomic and Environmental Valuation: 2 fractional worksBacterial Infections and Vaccines: 2 fractional worksEconomic and Financial Impacts of Cancer: 2 fractional worksCAR-T cell therapy research: 2 fractional worksStatistical Methods in Clinical Trials: 2 fractional worksGlobal Health Care Issues: 2 fractional works
Economics and EconometricsHealthPediatrics, Perinatology and Child HealthMicrobiology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 8 works
  2. 2 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
  3. 3 Vaccine Coverage and Hesitancy Health 2 works
  4. 4 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 2 works
  5. 5 Economic and Environmental Valuation Economics and Econometrics 2 works
  6. 6 Bacterial Infections and Vaccines Microbiology 2 works
  7. 7 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
  8. 8 CAR-T cell therapy research Oncology 2 works
  9. 9 Statistical Methods in Clinical Trials Statistics and Probability 2 works
  10. 10 Global Health Care Issues General Health Professions 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.0%not open51.0%

World: 28% of research is openly available.

with international co-authors65.2%domestic only34.8%

World: 19% is written across borders.

How has EVRAZ (United Kingdom)'s research output changed?

Output in 2018–2022 was 67% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in London

All research institutions in London

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.